Neuropathy Among Childhood Cancer Survivors

Monday, June 11, 2018
Childhood cancer treatment has improved significantly over the past 60 years, and a child who survives 5 or more years after diagnosis now has a life span comparable to that of other children of that age. However, some children experience adverse effects of treatment, and some of these effects have long-term implications.

Chemotherapy-induced peripheral neuropathy (CIPN) is a potentially long-lasting adverse effect of treatment with commonly used agents, such as the vinca alkaloids, cisplatin, and carboplatin. To assess long-term effects of CIPN, researchers compared 121 childhood cancer survivors who were treated with chemotherapy for an extracranial malignancy before age 17 to healthy age-matched controls. The childhood cancer survivors had neurotoxicity assessments at a median age of 16 years, which was a median of 8.5 years after treatment completion.

Results of the study, published in JAMA Neurology, showed that CIPN was observed in 54 of 107 children (50%) who were treated with neurotoxic chemotherapy and met study inclusion criteria. Sensory deficits were more commonly observed in the legs and functional deficits were observed in manual dexterity and balance.

The researchers concluded that CIPN is prevalent among childhood cancer survivors and persists long term. These findings have implications for cancer rehabilitation as well as the development of neuroprotective agents.


Talk about this article with nurses and others in the oncology community in the General Discussions Oncology Nursing News discussion group.
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN
Blog Info
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN is an oncology nursing consultant and editor-in-chief of Oncology Nursing News.
Author Bio
Lisa Schulmeister, MN, RN, ACNS-BC, FAAN, is the Editor-in-Chief for OncLive Nursing. She is an oncology nursing consultant and adjunct assistant professor of nursing at Louisiana State Health Sciences Center in New Orleans, LA. She provides continuing nursing education to nurses across the Unites States, is active in several professional nursing organizations, and is intrigued by the many ways nurses use technology to communicate.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.